Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Molecular Cytogenetics Market Forecast: Value Set To Climb From $3.42 Billion To $5.13 Billion
The molecular cytogenetics market has demonstrated significant expansion in recent years. Its valuation is anticipated to climb from $3.1 billion in 2025 to $3.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.4%. This historical growth can be linked to factors like the increasing occurrence of genetic disorders, the broader availability of cancer diagnostic testing, the progression of academic and clinical genetics research, the supply of advanced laboratory instruments, and the rising need for chromosomal abnormality detection.
The molecular cytogenetics market size is projected to experience substantial growth in the coming years. It is forecast to reach $5.13 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This expansion during the forecast period can be attributed to the increasing adoption of personalized medicine approaches, rising investments in genomic research, the expansion of precision oncology diagnostics, a growing demand for integrated cytogenetic workflows, and continuous advancements in imaging and molecular analysis technologies. Major trends anticipated in the forecast period encompass the increasing adoption of FISH and CGH technologies, a rising use of genomic profiling in oncology, the growing integration of automated cytogenetic platforms, the expansion of bioinformatics-driven data interpretation, and an enhanced focus on high-throughput cytogenetic analysis.
Get A Free Sample Report With In-Depth Market Insights:
Molecular Cytogenetics Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of genetic disorders and cancer is projected to stimulate the expansion of the molecular cytogenetics market in the future. Cancer is characterized by the uncontrolled multiplication of abnormal cells that spread within the body. This growing burden stems from genetic predispositions, environmental influences, and age-related factors, leading to a greater demand for patient diagnostic assessments. Molecular cytogenetics aids clinical decisions through precise identification of chromosomal abnormalities, including missing, broken, or rearranged chromosomes, which assists in diagnosing congenital disorders, genetic diseases, and various cancers. As an illustration, in July 2025, the National Blood Authority, an Australia-based blood management agency, reported 2,788 patients suffering from hereditary haemophilia A (HMA) in 2023–2024, an increase from 2,681 patients in 2022–2023. Consequently, the escalating prevalence of genetic disorders and cancer is fueling the expansion of the molecular cytogenetics market.
Molecular Cytogenetics Market Segment Landscape: Which Areas Lead Development?
The molecular cytogenetics market covered in this report is segmented –
1) By Product: Instruments, Kits And Reagents, Software, Services
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users
Subsegments:
1) By Instruments: Fluorescence In Situ Hybridization (FISH) Systems, Microarray Platforms, Imaging Systems
2) By Kits And Reagents: DNA Extraction Kits, Hybridization Kits, Staining Kits
3) By Software: Data Analysis Software, Image Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Reporting Software
4) By Services: Custom Research Services, Technical Support Services, Consulting Services, Training Services, Quality Control Services
Molecular Cytogenetics Market Trends Powering Strategic Industry Growth
Leading companies operating in the molecular cytogenetics market are developing innovative products, such as the LUTHOR High-Definition Single Cell 3′ mRNA-Seq Kit, to meet increasing demand and capitalize on expanding market opportunities. This kit revolutionizes single-cell RNA sequencing by utilizing an RNA-amplification-based method that can detect virtually every single mRNA molecule present in the cell. For example, in November 2023, Lexogen GmbH, an Austria-based biotechnology firm, introduced the LUTHOR High-Definition Single Cell 3′ mRNA-Seq Kit. This cutting-edge protocol establishes new standards in single-cell RNA sequencing, allowing for the detection of even a single gene copy within a cell and capturing 95% of expressed genes at a 1 million read depth. The exceptional sensitivity of LUTHOR HD is attributed to its innovative THOR (T7 High-resolution Original RNA amplification) technology, which amplifies RNA directly from the original mRNA, thereby overcoming the limitations associated with low-copy transcripts.
Molecular Cytogenetics Market Leading Players And Competitive Positioning
Major companies operating in the molecular cytogenetics market are Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, F. Hoffmann-La Roche AG, Cytognomix Inc, Empire Genomics LLC, Genial Genetic Solutions Ltd., BioChain Institute Inc, BioGenex Laboratories Inc, Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, SciGene Corporation, SkylineDx B.V., Roche Diagnostics Corporation
View The Full Molecular Cytogenetics Market Report:
Molecular Cytogenetics Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the molecular cytogenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
